Assessment of a bioactive compound for its potential antiinflammatory property by tight junction permeability

Phytotherapy Research

Volumn 19, Issue 12, 2005, Pages 1009-1012

  Bai, Young Hoon ^a   Pak, Sok Cheon ^b   Lee, Seung Hoo ^b   Bae, Chun Sik ^c   Prosser, Colin ^d   Stelwagen, Kerst ^d   Lee, Jin Hee ^e   Park, Soon Duck ^e  

^a Chosun University College of Medicine   (South Korea)

^b Hamilton College of Oriental Medicine   (New Zealand)

^c Chonnam National University   (South Korea)

^d RUAKURA RESEARCH CENTRE   (New Zealand)

^e Sesang Life Science Inc   (South Korea)

Author keywords

Antiinflammatory; Lactobacillus; Permeability; Tight junction; Transepithelial electrical resistance

Indexed keywords

ANTIINFLAMMATORY AGENT; EGTAZIC ACID; LIFREE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG PENETRATION; ELECTRIC RESISTANCE; EPITHELIUM CELL; FERMENTATION; FRUIT; INTESTINE EPITHELIUM CELL; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; MOUSE; NONHUMAN; RAT; SACCHAROMYCES CEREVISIAE; TIGHT JUNCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL PRODUCTS; CELL PROLIFERATION; EPITHELIAL CELLS; FERMENTATION; FRUIT; LACTOBACILLUS; MICE; NIH 3T3 CELLS; PLANT EXTRACTS; RATS; TIGHT JUNCTIONS;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; SACCHAROMYCES CEREVISIAE;

EID: 31144468286     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1772     Document Type: Article

References (21)

1. Baumgart DC, Dignass AU. 2002. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 5: 685-694.
2. Bjarnason I, MacPherson A, Hollander D. 1995. Intestinal permeability: an overview. Gastroenterology 108: 1566-1581.
3. Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG. 2002. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell 13: 3218-3234.
4. Ganjam LS, Thornton WH, Marshall RT, MacDonald RS. 1997. Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells. J Dairy Sci 80: 2325-2329.
5. Han X, Uchiyama T, Sappington PL et al. 2003. NAD+ ameliorates inflammation-induced epithelial barrier dysfunction in cultured enterocytes and mouse ileal mucosa. J Pharmacol Exp Ther 307: 443-449.
6. Huber JD, Hau VS, Borg L, Campos CR, Egleton RD, Davis TP. 2002. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. Am J Physiol Heart Circ Physiol 283: H1531-H1537.
7. LeBlanc JG, Matar C, Valdez JC, LeBlanc J, Perdigon G. 2002. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J Dairy Sci 85: 2733-2742.
8. Madsen KL, Lewis SA, Tavernini MM, Hibbard J, Fedorak RN. 1997. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 113: 151-159.
9. Matar C, Valdez JC, Medina M, Rachid M, Perdigon G. 2001. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J Dairy Res 68: 601-609.
10. Mazzon E, Puzzolo D, Caputi AP, Cuzzocrea S. 2002. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol Med 8: 353-366.
11. Niedzielin K, Kordecki H, Birkenfeld B. 2001. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13: 1143-1147.
12. Ormrod DJ, Miller TE. 1991. The anti-inflammatory activity of a low molecular weight component derived from the milk of hyperimmunized cows. Agents Actions 32: 160-166.
13. Sappington PL, Han X, Yang R, Delude RL, Fink MP. 2003. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J Pharmacol Exp Ther 304: 464-476.
14. Schmitz H, Barmeyer C, Fromm M et al. 1999. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116: 301-309.
15. Schneeberger EE, Lynch RD. 1992. Structure, function, and regulation of cellular tight junctions. Am J Physiol 262: L647-L661.
16. Seppo L, Jauhiainen T, Poussa T, Korpela R. 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77: 326-330.
17. Steeber DA, Tedder TF. 2000. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol Res 22: 299-317.
18. Stelwagen K, Ormrod DJ. 1998. An anti-inflammatory component derived from milk of hyperimmunised cows reduces tight junction permeability in vitro. Inflamm Res 47: 384-388.
19. von der Weid T, Ibnou-Zekri N, Pfeifer A. 2002. Novel probiotics for the management of allergic inflammation. Dig Liver Dis 34 (Suppl 2): S25-S28.
20. Van F, Polk DB. 2002. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277: 50959-50965.
21. Zech JC, Pouvreau I, Cotinet A, Goureau O, Le Varlet B, de Kozak Y. 1998. Effect of cytokines and nitric oxide on tight junctions in cultured rat retinal pigment epithelium. Invest Ophthalmol Vis Sci 39: 1600-1608.